Modulation of Differentiation-related Gene 1 Expression by Cell Cycle Blocker Mimosine, Revealed by Proteomic Analysis*

l-Mimosine, a plant amino acid, can reversibly block mammalian cells at late G1 phase and has been found to affect translation of mRNAs of the cyclin-dependent kinase inhibitor p27, eIF3a (eIF3 p170), and ribonucleotide reductase M2. The effect of mimosine on the expression of these genes may be essential for the G1 phase arrest. To determine additional genes that may be early respondents to the mimosine treatment, we performed two-dimensional gel electrophoretic analysis of [35S]methionine-labeled cell lysates followed by identification of the altered protein spots by LC-tandem mass spectrometry. In this study, the synthesis of two protein spots (MIP42 and MIP17) was found to be enhanced by mimosine, whereas the formation of another protein spot (MSP17) was severely blocked following mimosine treatment. These protein spots, MIP42, MIP17, and MSP17, were identified to be differentiation-related gene 1 (Drg-1; also called RTP, cap43, rit42, Ndrg-1, and PROXY-1), deoxyhypusine-containing eIF5A intermediate, and mature hypusine-containing eIF5A, respectively. The effect of mimosine on eIF5A maturation was due to inhibition of deoxyhypusine hydroxylase, the enzyme catalyzing the final step of hypusine biosynthesis in eIF5A. The mimosine-induced expression of Drg-1 was mainly attributable to increased transcription likely by the c-Jun/AP-1 transcription factor. Because induction of Drg-1 is an early event after mimosine treatment and is observed before a notable reduction in the steady-state level of mature eIF5A, eIF5A does not appear to be involved in the modulation of Drg-1 expression.

[1]  K. Kulp,et al.  Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells. , 1996, Toxicology and applied pharmacology.

[2]  Jian-Ting Zhang,et al.  EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression. , 2003, Molecular biology of the cell.

[3]  R. Grady,et al.  Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors: a hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (HIV-1). , 1998, Biochemical pharmacology.

[4]  S. Aaronson,et al.  Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. , 1998, Cancer research.

[5]  R. Tyrrell,et al.  A novel iron chelator that does not induce HIF-1 activity. , 2002, Free radical biology & medicine.

[6]  M. H. Park,et al.  Hypusine is essential for eukaryotic cell proliferation. , 1993, Biological signals.

[7]  Michael L. Cleary,et al.  Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor , 1990, Cell.

[8]  J. Hamlin,et al.  The dual effect of mimosine on DNA replication. , 1997, Experimental cell research.

[9]  W. Dinjens,et al.  A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[10]  R. Kennett,et al.  Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells. , 2001, Cancer research.

[11]  Qingzhen Zhao,et al.  DNA methylation contributes to expression of the human neurotensin/neuromedin N gene. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[12]  M. Lalande,et al.  A reversible arrest point in the late G1 phase of the mammalian cell cycle. , 1990, Experimental cell research.

[13]  B. Evers,et al.  Site-specific DNA methylation contributes to neurotensin/neuromedin N expression in colon cancers. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[14]  R. Pincheira,et al.  Two subcellular localizations of eIF3 p170 and its interaction with membrane-bound microfilaments: implications for alternative functions of p170. , 2001, European journal of cell biology.

[15]  K. Salnikow,et al.  Role of Ca(2+) in the regulation of nickel-inducible Cap43 gene expression. , 1999, Toxicology and applied pharmacology.

[16]  H. Kondoh,et al.  N-myc-dependent repression of Ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant , 1999, Mechanisms of Development.

[17]  M. H. Park.  The identification of an eukaryotic initiation factor 4D precursor in spermidine-depleted Chinese hamster ovary cells. , 1988, The Journal of biological chemistry.

[18]  F. Bosman,et al.  Expression of NDRG1, a differentiation-related gene, in human tissues , 2002, Histochemistry and Cell Biology.

[19]  Juhyung Lee,et al.  New and known symmetrical curcumin derivatives inhibit the formation of Fos-Jun-DNA complex. , 2002, Cancer letters.

[20]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[21]  J. Hershey,et al.  Protein synthesis initiation factor eIF-4D. Functional comparison of native and unhypusinated forms of the protein. , 1989, The Journal of biological chemistry.

[22]  W. Hung,et al.  Modulation of cell cycle regulatory protein expression and suppression of tumor growth by mimosine in nude mice. , 2000, International journal of oncology.

[23]  T. Commes,et al.  Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. , 1999, Biochimica et biophysica acta.

[24]  L. Staiano‐Coico,et al.  Detection of a sub‐set of polysomal mRNAs associated with modulation of hypusine formation at the G1‐S boundary Proposal of a role for eIF‐5A in onset of DNA replication , 1995, FEBS letters.

[25]  M. H. Park,et al.  Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. , 1993, BioFactors.

[26]  P. Dijkwel,et al.  The plant amino acid mimosine may inhibit initiation at origins of replication in Chinese hamster cells , 1992, Molecular and cellular biology.

[27]  K. Miura,et al.  The Drg-1 gene suppresses tumor metastasis in prostate cancer. , 2003, Cancer research.

[28]  T. Miyata,et al.  Homocysteine-respondent Genes in Vascular Endothelial Cells Identified by Differential Display Analysis , 1996, The Journal of Biological Chemistry.

[29]  M. Blagosklonny,et al.  Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. , 2000, Cancer research.

[30]  Chul-hak Yang,et al.  Inhibition of fos-jun-DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells. , 1998, Cancer letters.

[31]  H. Ford,et al.  Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. , 2000, Cancer research.

[32]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[33]  G. Kontoghiorghes,et al.  Site specificity of iron removal from transferrin by α‐ketohydroxypyridine chelators , 1985 .

[34]  M. H. Park,et al.  The biosynthesis of protein-bound hypusine (N epsilon -(4-amino-2-hydroxybutyl)lysine). Lysine as the amino acid precursor and the intermediate role of deoxyhypusine (N epsilon -(4-aminobutyl)lysine). , 1982, The Journal of biological chemistry.

[35]  M. Blagosklonny,et al.  The Regulation of Hypoxic Genes by Calcium Involves c-Jun/AP-1, Which Cooperates with Hypoxia-Inducible Factor 1 in Response to Hypoxia , 2002, Molecular and Cellular Biology.

[36]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[37]  J. Hershey,et al.  Changes in eIF-4D hypusine modification or abundance are not correlated with translational repression in HeLa cells. , 1986, The Journal of biological chemistry.

[38]  C. Elferink,et al.  Quantitative RT-PCR on CYP1A1 heterogeneous nuclear RNA: a surrogate for the in vitro transcription run-on assay. , 1996, BioTechniques.

[39]  J. Jakus,et al.  Features of the spermidine-binding site of deoxyhypusine synthase as derived from inhibition studies. Effective inhibition by bis- and mono-guanylated diamines and polyamines. , 1993, The Journal of biological chemistry.

[40]  Artur,et al.  Specific inhibition of eIF-5A and collagen hydroxylation by a single agent. Antiproliferative and fibrosuppressive effects on smooth muscle cells from human coronary arteries. , 1995, The Journal of clinical investigation.

[41]  D. N. Perkins,et al.  Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.

[42]  M. Lalande,et al.  Inhibition of the G1-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation. , 1994, Biochimica et biophysica acta.

[43]  R. Pincheira,et al.  Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth , 2004, Oncogene.

[44]  W. K. Miskimins,et al.  Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1). , 2000, Experimental cell research.

[45]  P. Cook,et al.  Mimosine arrests the cell cycle after cells enter S-phase. , 1996, Experimental cell research.

[46]  J. Swinnen,et al.  The differentiation‐related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells , 1999, FEBS letters.

[47]  G. Eliopoulos,et al.  Decreased expression of c‐myc oncoprotein by peripheral blood mononuclear cells in thalassaemia patients receiving desferrioxamine , 1998, European journal of haematology.

[48]  T. McCaffrey,et al.  Antiproliferative and Fibrosuppressive Effects on Smooth Muscle Cells from Human Coronary Arteries , 1995 .

[49]  K. Salnikow,et al.  Cap43, a novel gene specifically induced by Ni2+ compounds. , 1998, Cancer research.

[50]  H. Kondoh,et al.  The leukemogenic transcription factor E2a-Pbx1 induces expression of the putative N-myc and p53 target gene NDRG1 in Ba/F3 cells , 2001, Leukemia.

[51]  C. Graham,et al.  Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells. , 2000, Biochemical and biophysical research communications.

[52]  D. Dobbs,et al.  Mimosine differentially inhibits DNA replication and cell cycle progression in somatic cells compared to embryonic cells of Xenopus laevis. , 1995, Experimental cell research.

[53]  T. Lin,et al.  Cloning and characterization of TDD5, an androgen target gene that is differentially repressed by testosterone and dihydrotestosterone. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[54]  W. Tsai,et al.  Toxic action of mimosine. I. Inhibition of mitosis and DNA synthesis of H.Ep-2 cell by mimosine and 3,4-dihydroxypyridine. , 1971, Toxicon.